PL425235A1 - Zastosowanie izoksantohumolu - Google Patents

Zastosowanie izoksantohumolu

Info

Publication number
PL425235A1
PL425235A1 PL425235A PL42523518A PL425235A1 PL 425235 A1 PL425235 A1 PL 425235A1 PL 425235 A PL425235 A PL 425235A PL 42523518 A PL42523518 A PL 42523518A PL 425235 A1 PL425235 A1 PL 425235A1
Authority
PL
Poland
Prior art keywords
isoxanthohumol
application
prevention
treatment
ureterolithiasis
Prior art date
Application number
PL425235A
Other languages
English (en)
Other versions
PL238123B1 (pl
Inventor
Ewa Grela
Joanna Kozłowska
Mirosław Anioł
Agnieszka Grabowiecka
Bartłomiej Potaniec
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu, Politechnika Wrocławska filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL425235(22)20180416A priority Critical patent/PL238123B1/pl
Publication of PL425235A1 publication Critical patent/PL425235A1/pl
Publication of PL238123B1 publication Critical patent/PL238123B1/pl

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest zastosowanie izoksantohumolu o wzorze 1, do wytwarzania leku i/lub jako składnika produktów leczniczych do leczenia i zapobiegania kamicy nerkowej, kamicy moczowodu oraz kamienia w obrębie dolnych dróg moczowych, jak również zapalenia pęcherza moczowego oraz do wytwarzania suplementów diety, środków żywieniowych lub jako składnika żywności funkcjonalnej, stosowanych wspomagająco w leczeniu i w profilaktyce tych chorób.
PL425235(22)20180416A 2018-04-16 2018-04-16 Zastosowanie izoksantohumolu PL238123B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL425235(22)20180416A PL238123B1 (pl) 2018-04-16 2018-04-16 Zastosowanie izoksantohumolu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL425235(22)20180416A PL238123B1 (pl) 2018-04-16 2018-04-16 Zastosowanie izoksantohumolu

Publications (2)

Publication Number Publication Date
PL425235A1 true PL425235A1 (pl) 2019-10-21
PL238123B1 PL238123B1 (pl) 2021-07-05

Family

ID=68238724

Family Applications (1)

Application Number Title Priority Date Filing Date
PL425235(22)20180416A PL238123B1 (pl) 2018-04-16 2018-04-16 Zastosowanie izoksantohumolu

Country Status (1)

Country Link
PL (1) PL238123B1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090258094A1 (en) * 2007-08-15 2009-10-15 Flaxan Gmbh & Co. Kg Xanthohumol-enriched hop extract

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090258094A1 (en) * 2007-08-15 2009-10-15 Flaxan Gmbh & Co. Kg Xanthohumol-enriched hop extract

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
F. STEVENS A.W. TAYLOR LE. CLAWSON M.L. DEINZER, QUANTITATIVE ANALYSIS OF XANTHOHUMOL AND RELATED PRENYLFLAVONOIDS IN HOPS AND BEER BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, 1999 *
M. DUSEK, A NOVEL APPROACH FOR IDENTIFICATION OF BIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS IN COMPLEX MATRICES USING HYBRID QUADRUPOLE-ORBITRAP MASS SPECTROMETER: A PROMISING TOOL FOR TESTING ANTIMICROBIAL ACTIVITY OF HOPS, 2016 *
STOMPOR M ŻAROWSKA B., ANTIMICROBIAL ACTIVITY OF XANTHOHUMOL AND ITS 1-4 SELECTED STRUCTURAL ANALOGUES, 2016 *

Also Published As

Publication number Publication date
PL238123B1 (pl) 2021-07-05

Similar Documents

Publication Publication Date Title
GEP20257731B (en) Substituted aminothiazoles as dgkzeta inhibitors for immune activation
EP4553071A3 (en) Methods for improving mitophagy in subjects
MA33075B1 (fr) Composition destinee a la regulation du metabolism des lipides
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
EP3318251A3 (en) Composition for preventing or treating obesity or lipid-related metabolic disease
BR112018076800A2 (pt) derivado de guanidina, medicamento, inibidor da proteína 1 da translocação de linfoma de tecido linfóide associado com mucosa, e, agente terapêutico ou profilático.
MX2019010218A (es) Derivados de pirazol como inhibidores de bromodominio.
RU2008138358A (ru) Композиция с фиксированной дозой фитата и цинка
MY195760A (en) Use of IDHP in Preparation of Drug or Health Product for Prevention and Treatment of Coronary Atherosclerosis Disease
MX2021003651A (es) Formulacion que comprende aceite ozonizado en el tratamiento de un tumor.
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
PL425235A1 (pl) Zastosowanie izoksantohumolu
PL425241A1 (pl) Zastosowanie 2'-hydroksychalkonu
PL425242A1 (pl) Zastosowanie 3'-amino-4-karboksychalkonu
PL425240A1 (pl) Zastosowanie 7-aminoflawonu
PL425239A1 (pl) Zastosowanie 2'-hydroksy-4-metylochalkonu
PL425238A1 (pl) Zastosowanie 2'-hydroksy-4-etylochalkonu
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
ITUA20164387A1 (it) Composizione farmaceutica comprendente Cetraria islandica Ach., sodio ialuronato e una soluzione salina per il trattamento di affezioni dell'apparato respiratorio.
BR112023025213A2 (pt) Combinação de um corpo cetônico ou composto cetogênico com um analgésico ou antioxidante
JOP20220313A1 (ar) تركيبة دوائية مائية من الليفيليماب وإستخدامها
WO2022065970A3 (ko) 천연물 혼합 추출물을 포함하는 코로나바이러스 감염 예방 또는 치료용 조성물
PL423329A1 (pl) Zastosowanie jagody kamczackiej Lonicera caerulea L. var. Kamtschatica lub jej tkanek lub ich wytworów, zwłaszcza ekstraktu z owoców
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
PL421363A1 (pl) Zastosowanie derenia właściwego Cornus mas L. lub jego tkanek lub ich wytworów, zwłaszcza ekstraktu z owoców